News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,546 Results
Type
Article (26579)
Company Profile (115)
Press Release (358852)
Section
Business (101711)
Career Advice (527)
Deals (17963)
Drug Delivery (68)
Drug Development (38555)
Employer Resources (77)
FDA (10627)
Job Trends (9959)
News (174589)
Policy (20569)
Tag
Academia (2102)
Africa (507)
Alliances (28231)
Alzheimer's disease (744)
Approvals (10593)
Arizona (83)
Artificial intelligence (52)
Asia (20848)
Australia (3726)
Bankruptcy (143)
Best Places to Work (8672)
Biosimilars (44)
Biotechnology (64)
C2C Services and Suppliers (41985)
California (975)
Canada (602)
Cancer (184)
Career advice (485)
Cell therapy (52)
China (79)
Clinical research (30358)
Collaboration (70)
Colorado (43)
Connecticut (52)
COVID-19 (2102)
Cystic fibrosis (43)
Data (140)
Diabetes (51)
Diagnostics (4575)
Drug pricing (62)
Earnings (32486)
Employer resources (66)
Europe (46299)
Events (69760)
Executive appointments (94)
FDA (10760)
Florida (158)
Funding (82)
Gene therapy (42)
Georgia (51)
GLP-1 (282)
Government (4036)
Healthcare (14792)
Hotbed/Location (260490)
Illinois (163)
Indiana (129)
Infectious disease (2123)
Inflammatory bowel disease (59)
Interviews (59)
IPO (7605)
Job creations (1399)
Job search strategy (448)
Kansas (72)
Layoffs (150)
Legal (3874)
Lung cancer (40)
Maine (54)
Manufacturing (51)
Maryland (255)
Massachusetts (836)
Medical device (9129)
Medtech (9132)
Mergers & acquisitions (10323)
Metabolic disorders (163)
Michigan (71)
Minnesota (110)
Neuroscience (823)
New Jersey (355)
New York (327)
NextGen Class of 2024 (4960)
Non-profit (3906)
North Carolina (394)
Northern California (465)
Obesity (108)
Ohio (66)
Opinion (101)
Pennsylvania (387)
People (31708)
Phase I (9654)
Phase II (11904)
Phase III (10829)
Pipeline (59)
Policy (39)
Postmarket research (1565)
Preclinical (3060)
Press Release (47)
Rare diseases (75)
Real estate (2823)
Regulatory (13290)
Research institute (1899)
Resumes & cover letters (41)
South America (663)
Southern California (394)
Startups (2074)
Texas (109)
United States (5040)
Utah (38)
Vaccines (369)
Washington State (175)
Weight loss (86)
Date
Today (86)
Last 7 days (411)
Last 30 days (1416)
Last 365 days (22758)
2024 (15762)
2023 (24258)
2022 (33691)
2021 (37143)
2020 (37577)
2019 (33271)
2018 (24904)
2017 (17710)
2016 (18858)
2015 (21430)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13905)
2010 (11929)
385,546 Results for "syneos health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients Honored for Notable Biopharmaceutical Industry Impact
Syneos Health® announced PM360 has named six distinguished colleagues as recipients of its 10th Annual ELITE 100 Awards.
May 23, 2024
·
3 min read
Bio NC
Syneos Health Releases 2024 Dealmakers’ Intentions Survey
Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, released its Dealmakers’ Intentions Survey.
January 9, 2024
·
2 min read
Business
Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion
Odyssey Health, Inc. has selected Syneos Health to support its Investigational New Drug (IND) Application.
November 16, 2023
·
4 min read
Business
Syneos Health Names Terttu Haring President, Clinical Sites & Patients
Syneos Health® has announced the appointment of Terttu Haring, MD, as President, Clinical Sites & Patients.
September 26, 2023
·
3 min read
Lone Star Bio
Elligo Health Research Announces Expansion of Study Marketplace With Syneos Health
Elligo Health Research®, the largest healthcare-enabling research organization, announced it is expanding its Study Marketplace platform with Syneos Health, a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success.
October 5, 2023
·
2 min read
Bio NC
Syneos Health Closes Transaction with Private Investment Firms
Syneos Health, Inc. announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital.
September 28, 2023
·
5 min read
Bio NC
Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity
Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced a strategic collaboration that will expand its relationship with Oracle.
September 12, 2023
·
3 min read
Business
Syneos Health Appoints Colin Shannon as Chief Executive OfficerIndustry Veteran Brings Decades of Experience Driving Growth at Global Biopharmaceutical Solutions Organizations
Syneos Health, Inc., a leading fully integrated biopharmaceutical solutions organization, announced that Colin Shannon has been appointed Chief Executive Officer, effective immediately.
October 3, 2023
·
4 min read
Business
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer
Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced the appointment of Hillary Bochniak as Chief Human Resources Officer, effective July 10, 2023.
July 10, 2023
·
2 min read
Bio NC
Syneos Health Stockholders Approve Agreement with Private Investment Consortium
Syneos Health, Inc. announced that the Company’s stockholders approved an agreement to take the Company private through an acquisition by a consortium of private investment firm affiliates comprised of Elliott Investment Management L.P., Patient Square Capital, and Veritas Capital at a special meeting of stockholders held earlier.
August 2, 2023
·
6 min read
1 of 38,555
Next